78 related articles for article (PubMed ID: 9187103)
1. Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness.
Smith MK; Goral MA; Wright JH; Matrisian LM; Morris RJ; Klein-Szanto AJ; Gilmour SK
Cancer Res; 1997 Jun; 57(11):2104-8. PubMed ID: 9187103
[TBL] [Abstract][Full Text] [Related]
2. Role of ornithine decarboxylase in epidermal tumorigenesis.
Clifford A; Morgan D; Yuspa SH; Soler AP; Gilmour S
Cancer Res; 1995 Apr; 55(8):1680-6. PubMed ID: 7712475
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
4. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress.
Otieno MA; Kensler TW
Cancer Res; 2000 Aug; 60(16):4391-6. PubMed ID: 10969783
[TBL] [Abstract][Full Text] [Related]
5. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
[TBL] [Abstract][Full Text] [Related]
6. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter element.
Wright PS; Cooper JR; Cross-Doersen DE; Miller JA; Chmielewski PA; Wagner RL; Streng KA; Flanagan MA
Cell Growth Differ; 1995 Sep; 6(9):1097-102. PubMed ID: 8519686
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
9. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
10. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
[TBL] [Abstract][Full Text] [Related]
13. In vivo invasion assay of low passage cultured cells derived from human lung cancer using deepithelialized rat tracheas xenotransplanted into nude mice.
Yamakawa H; Baba M; Yamaguchi Y
Cancer Res; 1990 Nov; 50(22):7358-63. PubMed ID: 2224863
[TBL] [Abstract][Full Text] [Related]
14. Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation.
Hibshoosh H; Johnson M; Weinstein IB
Oncogene; 1991 May; 6(5):739-43. PubMed ID: 1711188
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
16. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
17. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
18. Preneoplastic and neoplastic growth of xenotransplanted lung-derived human cell lines using deepithelialized rat tracheas.
Baba M; Klein-Szanto AJ; Trono D; Obara T; Yoakum GH; Masui T; Harris CC
Cancer Res; 1987 Jan; 47(2):573-8. PubMed ID: 3791242
[TBL] [Abstract][Full Text] [Related]
19. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
Mercapide J; Lopez De Cicco R; Castresana JS; Klein-Szanto AJ
Int J Cancer; 2003 Sep; 106(5):676-82. PubMed ID: 12866026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
